- Home
- SOFI vs TEVA Comparison
SOFI vs TEVA Comparison
Compare SOFI & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SOFI | TEVA |
|---|---|---|
| Founded | 2011 | 1901 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Diversified Financial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0B | 30.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SOFI | TEVA |
|---|---|---|
| Price | $27.03 | $29.74 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 17 | 9 |
| Target Price | $24.70 | ★ $29.78 |
| AVG Volume (30 Days) | ★ 65.6M | 10.6M |
| Earning Date | 01-26-2026 | 01-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 357.55 | N/A |
| EPS | 0.54 | ★ 0.62 |
| Revenue | $3,290,639,000.00 | ★ $16,776,000,000.00 |
| Revenue This Year | $37.00 | $4.74 |
| Revenue Next Year | $27.42 | $0.48 |
| P/E Ratio | $50.32 | ★ $48.27 |
| Revenue Growth | ★ 30.62 | 0.02 |
| 52 Week Low | $8.60 | $12.47 |
| 52 Week High | $32.73 | $30.20 |
Technical Indicators
Market Signals| Indicator | SOFI | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 46.04 | 79.52 |
| Support Level | $26.48 | $28.00 |
| Resistance Level | $27.68 | $30.20 |
| Average True Range (ATR) | 1.13 | 0.65 |
| MACD | -0.17 | 0.18 |
| Stochastic Oscillator | 32.84 | 92.58 |
Price Performance
Historical ComparisonAbout SOFI SoFi Technologies Inc.
SoFi is a financial-services company that was founded in 2011 and is based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020, the company also offers payment and account services for debit cards and digital banking.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.